Latest News

Market forces rained on the parade of V.S. Industry Berhad ( KLSE:VS ) shareholders today, when the analysts downgraded...

Readers hoping to buy Hexaware Technologies Limited ( NSE:HEXT ) for its dividend will need to make their move shortly...

Let's talk about the popular NetEase, Inc. ( HKG:9999 ). The company's shares saw a double-digit share price rise of...

The board of KITZ Corporation ( TSE:6498 ) has announced that it will pay a dividend of ¥27.00 per share on the 12th of...

The board of Lasertec Corporation ( TSE:6920 ) has announced that it will pay a dividend on the 9th of March, with...

You can receive the average market return by buying a low-cost index fund. But you can make superior returns by picking...

As global markets navigate a complex landscape marked by economic uncertainties and geopolitical tensions, the Asian stock markets have shown resilience, with indices in China and Japan reflecting mixed but promising signals amid holiday-driven consumption boosts and technological advancements. In such an environment, dividend stocks can offer stability and potential income, making them an attractive option for investors looking to enhance their portfolios with reliable returns amidst...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

In October 2025, Asian markets are navigating a complex landscape marked by mixed economic signals and evolving monetary policies. As investors seek opportunities in this environment, identifying stocks that appear undervalued can be a strategic approach to potentially capitalize on market inefficiencies.

Deciding what to do with Amrize at this moment can feel a bit like standing at a crossroads. Maybe you have watched the price tick up 2.4% over the last week and wondered if this is the start of a comeback. At the same time, the stock is still down 9.0% for the past 30 days and has lost 16.4% so far this year, reflecting the market’s uncertainty and shifting appetite for risk in this sector. Some recent developments in the broader market seem to have nudged investors’ perception of Amrize,...

Bisalloy Steel Group recently issued 75,632 unquoted performance share rights as part of an employee incentive scheme, and announced its 2025 Annual General Meeting to be held virtually on November 6. These initiatives focus on aligning employee interests with company goals and providing greater transparency on strategic direction for stakeholders. We'll explore how Bisalloy's stepped-up employee engagement through performance share rights could influence its future investment...

Bakkt Holdings recently completed the sale of its loyalty business and appointed fintech veteran Mike Alfred to its board, marking a shift to a focused digital asset infrastructure platform. This transformation is underscored by renewed emphasis on Bitcoin, tokenized payments, and zero debt, signaling a significant realignment toward crypto and digital finance services. We'll explore how the company’s sharpened focus on digital assets and new leadership shapes Bakkt Holdings' investment...

SMC (TSE:6273) caught investors’ attention after CLSA elevated its stock rating. The move highlights the company’s solid global standing and expected tailwinds from future growth in technology and semiconductor production equipment. See our latest analysis for SMC. SMC’s recent share buyback completion and the upgrade from CLSA have set a more optimistic tone for investors, even as the company navigates a period of softer earnings and reduced guidance. While the total shareholder return over...

If you are staring at Fulton Financial’s ticker and wondering what comes next, you are not alone. The stock has quietly caught the eye of both cautious and optimistic investors after years of solid, if occasionally bumpy, performance. While volatility has crept in recently, with the price slipping -2.9% in the past week and -5.3% over the last month, the longer-term story is hard to ignore. Shares are up 10% over the past year, and an impressive 118.3% over five years, which suggests that...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Alto Neuroscience just received Fast Track designation from the FDA for ALTO-101, a new drug candidate aimed at treating cognitive impairment related to schizophrenia. This move could accelerate ALTO-101’s development and review process. See our latest analysis for Alto Neuroscience. The FDA’s support for ALTO-101 sparked fresh interest in Alto Neuroscience. However, despite the headline, its 1-year total shareholder return remains nearly flat while recent share price momentum has been...

If you are wrestling with the question of what to do with JD Logistics stock right now, you are not alone. Shares closed at 12.89 in the latest session and while the company's price hasn’t exactly skyrocketed lately, there are clear signals that the market's perception is quietly shifting. Over the last seven days, the stock notched a 0.5% gain. Over thirty days, it's up by 1.5%, and so far this year, JD Logistics has inched forward by 1.7%. Yet, if we zoom out, the one-year performance...

Are you eyeing Voestalpine and wondering if now is your moment to invest, hold, or walk away? You're not alone. After a year of eye-catching gains, this stock has many talking, and for good reason. Voestalpine has soared an impressive 81.7% year-to-date, with the past 30 days alone bringing investors a robust 15.2% return. Even looking beyond the short term, the stock is up nearly 100% over three years and 63.9% over five years. These moves hint at renewed optimism but may also reflect shifts...

Trying to figure out what to do with Saipem stock? You are not alone. Whether you are a new investor or someone tracking your positions closely, there is plenty to unpack behind this company’s recent moves. In just the past month, Saipem shares have climbed 10.2%, adding to a huge 32.6% surge over the past year. Even after some bumps earlier this year, and a five-year performance still showing a loss of 30.8%, the stock has more than tripled (up 272.4%) in the last three years. Those kinds of...

Yunfeng Financial Group (SEHK:376) has just been added to the S&P Global BMI Index, an event that often attracts the attention of investors and index funds. Index inclusions like this can generate new trading interest and increase liquidity. See our latest analysis for Yunfeng Financial Group. Shares have gained momentum following the S&P Global BMI Index inclusion, with a recent share price return of 5.1% year-to-date and a steady 3.7% total shareholder return over the past year, which hints...

As the Australian market experiences a slight pullback following a bullish surge, investors are keenly observing the ASX 200's movements amidst fluctuating global economic factors such as U.S. government shutdown concerns and rising gold prices. In this context, identifying undervalued stocks can be particularly appealing, as they may offer potential opportunities for growth in a market that is currently experiencing volatility and consolidation.

Trying to decide what to do with Chemed stock right now? You are not alone. Shareholders and would-be investors alike have been watching the company’s journey with a mix of curiosity and concern. After all, Chemed’s story over the past year has not followed a gentle upward climb. Instead, it has seen some notable slides, including a 16.0% drop year-to-date and an even steeper 23.4% decline over the past 12 months. Even stretching out to five years, Chemed’s shares are down 5.9%, which can...

Thinking about your next move with American Homes 4 Rent? You are not alone. The real estate sector has kept investors guessing lately, and American Homes 4 Rent has seen its fair share of ups and downs. Over the past week, the stock held steady with a slight 0.1% bump, but the 30-day drop of 6.3% and a year-to-date slide of 11.2% might be giving some pause. Long-term holders have still netted a gain, with more than 22% over five years, but recent dips have many wondering whether there is...

In recent weeks, ProAssurance received a consensus "Hold" recommendation from six ratings firms, while Zacks Research raised its rating to "strong-buy" and institutional investors and hedge funds significantly increased their shareholdings. This combination of analyst upgrade and heightened institutional interest signals a shift in market sentiment and renewed confidence in the company’s outlook. We’ll examine how the increased institutional ownership may impact ProAssurance’s investment...